Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of thromBocytopenia With EltRombopag or Intravenous Immune Globulin (IVIG) Before and DurING Invasive Procedures in Patients With Immune ThrombocytoPenia- BRIDGING ITP Study

NCT01621204 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT01621204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01621204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of thromBocytopenia With EltRombopag or Intravenous Immune Globulin (IVIG) Before and DurING Invasive Procedures in Patients With Immune ThrombocytoPenia- BRIDGING ITP Study
Lead sponsor
McMaster University
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2012
Completion date
August 31, 2019
Enrollment
74 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

immune thrombocytopenic purpura